用黎曼ζ函数揭示生物医学数据发现的规律，预测何时加数据最有效。

How much data is enough to make a scientific discovery? As biomedical datasets scale to millions of samples and AI models grow in capacity, progress increasingly depends on predicting when additional data will substantially improve performance. In practice, model development often relies on empirical scaling curves measured across architectures, modalities, and dataset sizes, with limited theoretical guidance on when performance should improve, saturate, or exhibit cross-over behavior. We propose a scaling-law framework for cross-modal discoverability based on spectral structure of data covariance operators, task-aligned signal projections, and learned representations. Many performance metrics, including AUC, can be expressed in terms of cumulative signal-to-noise energy accumulated across identifiable spectral modes of an encoder and cross-modal operator. Under mild assumptions, this accumulation follows a zeta-like scaling law governed by power-law decay of covariance spectra and aligned signal energy, leading naturally to the appearance of the Riemann zeta function. Representation learning methods such as sparse models, low-rank embeddings, and multimodal contrastive objectives improve sample efficiency by concentrating useful signal into earlier stable modes, effectively steepening spectral decay and shifting scaling curves. The framework predicts cross-over regimes in which simpler models perform best at small sample sizes, while higher-capacity or multimodal encoders outperform them once sufficient data stabilizes additional degrees of freedom. Applications include multimodal disease classification, imaging genetics, functional MRI, and topological data analysis. The resulting zeta law provides a principled way to anticipate when scaling data, improving representations, or adding modalities is most likely to accelerate discovery.